| NCT ID | NCT06138405 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Behavior and Behavior Mechanisms |
| Study Type | INTERVENTIONAL |
| Enrollment | 264 participants |
| Start Date | 2026-04 |
| Primary Completion | 2028-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 264 participants in total. It began in 2026-04 with a primary completion date of 2028-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this behavioral, interventional clinical trial is to provide a specialized workshop training for dental providers (e.g., dentists, hygienists, assistants) to improve interactions with young children (2-10 years old) and parents/caregivers. The training is derived from a well-established behavior management program for preschoolers, Parent-Child Interaction Therapy (PCIT). The main questions it aims to answer are: * Change in behavior of dental providers * Acceptability of training by dental providers All participants will receive the same behavior training; however, one group will receive the training on a delayed schedule. Researchers will compare the immediate intervention and control group to see if the training was effective in the dental providers usage of skills.
Eligibility Criteria
Inclusion Criteria: Dental Providers * Licensed dentist, licensed or certified dental hygienist, or dental assistant * Provides (or willing to consider providing) dental treatment for children between 2 years and 10 years old -\>= 18 years old * Fluent in spoken and written English * Willing to be videotaped Parent/Caregivers * Understands spoken and written English * Willing to be videotaped * Provide signed and dated informed consent form * Willing to comply with all study procedures and be available for the duration of the study Child Dental Patients * Child between 2 years, 0 months, and 0 days, and 10 years, 11 months, 30 days old * Receiving preventive, restorative, emergency or any other dental treatment * Accompanied by a parent/caregiver * Understands spoken and written English * Willing to be videotaped * Parent/guardian provides signed and dated informed consent form * Provide assent (if 7+ years old and who do not have an obvious cognitive impairment or are "mentally immature") * Willing to comply with all study procedures and be available for the duration of the study * In good general health as evidenced by medical history Exclusion Criteria: * Cognitive impairment or developmental delay * Major medical problem in child * Autism or other developmental/neurodevelopmental disorders * Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
Contact & Investigator
Daniel W McNeil, PhD
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT06138405 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Behavior and Behavior Mechanisms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06138405 currently recruiting?
Yes, NCT06138405 is actively recruiting participants. Contact the research team at MDavis@dental.ufl.edu for enrollment information.
Where is the NCT06138405 trial being conducted?
This trial is being conducted at Fayetteville, United States, Gainesville, United States, Chapel Hill, United States, Morgantown, United States.
Who is sponsoring the NCT06138405 clinical trial?
NCT06138405 is sponsored by University of Florida. The principal investigator is Daniel W McNeil, PhD at University of Florida. The trial plans to enroll 264 participants.